Peter Hammerl
Max Planck Society
1 Papers
2 Citations
Peter Hammerl is an academic researcher from Max Planck Society. The author has contributed to research in topics: Tumor necrosis factor alpha & In vivo. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
TNF revisited: TNF‐independent antitumor activity in sera of mice sensitized with Propionibacterium acnes and challenged with lipopolysaccharide
TL;DR: The induction of a previously unrecognized antitumor activity in sera of mice sensitized with bacteria and subsequently challenged with lipopolysaccharide is described, which is distinct from TNF but displays tumor‐specific cytocidal activity in vitro as well as potent tumor‐regressing activity in vivo.
2